SIRT2 and myeloid leukemia: Although a previous report shows that knockdown or inhibition of Sirt2 with AC93253 in myeloid leukemia cells activates GSK3β through decreased Ser9 phosphorylation and prevents aberrant proliferation [10], little is known about the role of Sirt2 and GSK3β in ESCs.